Chronic treatment with mianserin prevents DOCA-salt hypertension in rats--evidence for the involvement of central 5-HT2 receptors

European Journal of Pharmacology
Andréia L S SilvaAndrew G Ramage


Central 5-HT2A receptors have been implicated in central volume control by activating a central angiotensinergic pathway to cause the release of vasopressin. Interestingly, to induce DOCA-salt hypertension in rats vasopressin release is required. Thus the present experiments were carried out to determine whether continuous blockade of these receptors over 20 days, with the non-selective 5-HT2 receptor antagonist mianserin would prevent the development of deoxycorticosterone acetate (DOCA)-salt hypertension. Mianserin, given i.c.v. 90 or 60 microg twice daily for 20 days prevented the development of hypertension in conscious rats receiving DOCA-salt but did not affect blood pressure in rats on salt alone. Further, the dose of 30 microg given i.c.v. twice daily had no effect nor did the vehicle, polyethylene glycol (PEG), on the development of the hypertension. Mianserin 90 microg twice daily i.c.v. was also shown to prevent the increase in fluid intake, urinary flow and sodium excretion caused by DOCA-salt treatment. These data indicate that this action of mianserin is not due to an intrinsic hypotensive action but an action which involves interference with the mechanism by which DOCA-salt treatment causes hypertension. Thus the...Continue Reading


Jan 1, 1982·Annals of the New York Academy of Sciences·T Saito, Y Yajima
Jan 1, 1994·British Journal of Pharmacology·A HilditchM J Robertson
Mar 8, 2000·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·N S BissoliA M Cabral
Apr 19, 2000·Hypertension Research : Official Journal of the Japanese Society of Hypertension·T KuboR Fukumori
Mar 27, 2001·British Journal of Pharmacology·M YuJ R McNeill
Oct 20, 2001·Journal of Korean Medical Science·C G Park, F H Leenen
Dec 26, 2001·Brain Research Bulletin·A G Ramage
Feb 18, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Gerard J MarekLawrence H Price

❮ Previous
Next ❯


Feb 24, 2011·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·H A Futuro NetoJ G P Pires

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.